NCT01737801

Brief Summary

Time to perform lung function test after chest physiotherapy in cystic fibrosis. The investigators study FEV1(forced expiratory volume in one second) and FVC (forced vital capacity).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2012

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 30, 2012

Completed
Last Updated

November 30, 2012

Status Verified

November 1, 2012

Enrollment Period

3.9 years

First QC Date

November 19, 2012

Last Update Submit

November 29, 2012

Conditions

Keywords

Lung functionPhysiotherapy

Outcome Measures

Primary Outcomes (1)

  • Lung function test. FEV1 and FVC

    2 days

Study Arms (1)

Lung function test

EXPERIMENTAL

Lung function test

Procedure: Lung function test

Interventions

Lung function test.

Also known as: Lung function test.
Lung function test

Eligibility Criteria

Age5 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with cystic fibrosis

You may not qualify if:

  • patients with cystic fibrosis who could not stay at the clinic for more than 4 hrs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, Stockholm County, Sweden

Location

MeSH Terms

Conditions

Cystic Fibrosis

Interventions

Respiratory Physiological Phenomena

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Intervention Hierarchy (Ancestors)

Circulatory and Respiratory Physiological Phenomena

Study Officials

  • Cecilia Rodriguez, Physio

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

November 19, 2012

First Posted

November 30, 2012

Study Start

February 1, 2008

Primary Completion

January 1, 2012

Study Completion

September 1, 2012

Last Updated

November 30, 2012

Record last verified: 2012-11

Locations